This inventor holds 1 USPTO granted patent. Top assignee: Broadmaster Biotech Corp.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Yi-Chen Chen in Hematocrit Measurement
Introduction
Yi-Chen Chen is an accomplished inventor based in Zhongli, Taiwan. He has made significant contributions to the field of medical technology, particularly in the measurement of hematocrit (HCT). His innovative approach has led to the development of a method and device that enhances the precision and reliability of hematocrit testing.
Latest Patents
Yi-Chen Chen holds a patent for a "Method of measuring hematocrit (HCT), and measurement device using the method." This invention utilizes an electrode test specimen to create a capacitor charging effect, resulting in a consequential change in discharge current for the measurement of hematocrit. The method involves several steps: first, blood is instilled into a pair of test electrodes, and a voltage is applied. Next, the voltage is removed, and the discharge current value is measured. Finally, a predetermined decision rule is referenced alongside the discharge current to obtain a hematocrit value for the blood. This innovative method significantly improves the accuracy of hematocrit measurements compared to conventional tests.
Career Highlights
Yi-Chen Chen is associated with Broadmaster Biotech Corp., where he continues to develop and refine his inventions. His work has garnered attention for its potential to enhance medical diagnostics and patient care.
Collaborations
Yi-Chen Chen collaborates with talented individuals such as Yu-Hsuan Tai and Shih-Jen Lu, who contribute to the innovative environment at Broadmaster Biotech Corp.
Conclusion
Yi-Chen Chen's contributions to hematocrit measurement represent a significant advancement in medical technology. His innovative methods and devices are poised to improve diagnostic accuracy and patient outcomes in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile